Skip to main content
VBIO
NASDAQ Life Sciences

NIAID Advances Entolimod Into Fully Funded GI-ARS Efficacy Study; December Data Readout

Tom Rudovsky · Reported by ACCESS Newswire
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$0.637
Mkt Cap
$1.33M
52W Low
$0.616
52W High
$67.5
52W Position info
3.4% above low
Off High info
99% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

VBIO is trading near its 52-week low of $0.616 (3.4% above the low) on light trading volume (0.1× avg).

Summary

NIAID's Radiation and Nuclear Countermeasures Program chose to move Entolimod into a therapeutic efficacy study at the Armed Forces Radiobiology Research Institute, days after positive safety findings. The government pays for the whole study, so Valion spends no cash — critical for a company that reported a $7.1M Q2 net loss with cash down to $2.1M and going concern doubt. The primary endpoint is survival in mice treated 24 hours after radiation exposure, with top-line results expected in early December. A survival benefit would strengthen Entolimod's case as a medical countermeasure under the FDA Animal Rule, where it already holds Fast Track and Orphan Drug designations. This comes as activist 3i, LP holds 46.17% and has been funding the company through preferred tranches, with a $100M shelf and $5M ATM in place. December data is the binary event.

At the time of this announcement, VBIO was trading at $0.64 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.3M. The 52-week trading range was $0.62 to $67.50. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: ACCESS Newswire.


Price Chart

Share this article

Copied!

VBIO - Latest Insights

VBIO
Nov 05, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.502
Real-time Price: $0.5199 info
Change: +$0.0179 (+4%) info
Market Cap: $1.121M info
VBIO
Nov 02, 2026, 7:50 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.585
Real-time Price: $0.5199 info
Change: -$0.0651 (-11%) info
Market Cap: $1.121M info
VBIO
Oct 29, 2026, 7:45 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.6758
Real-time Price: $0.5199 info
Change: -$0.1559 (-23%) info
Market Cap: $1.121M info
VBIO
Oct 27, 2026, 6:01 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.765
Real-time Price: $0.5199 info
Change: -$0.2451 (-32%) info
Market Cap: $1.121M info
VBIO
Oct 26, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.920
Real-time Price: $0.5199 info
Change: -$0.4001 (-43%) info
Market Cap: $1.121M info